These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28187279)

  • 1. Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection.
    Aravanis AM; Lee M; Klausner RD
    Cell; 2017 Feb; 168(4):571-574. PubMed ID: 28187279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Analysis of DNA and RNA Sequencing Data Obtained from Liquid Biopsies.
    Marass F; Castro-Giner F; Szczerba BM; Jahn K; Kuipers J; Aceto N; Beerenwinkel N
    Recent Results Cancer Res; 2020; 215():347-368. PubMed ID: 31605238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into cancer biology through next-generation sequencing.
    Nik-Zainal S
    Clin Med (Lond); 2014 Dec; 14 Suppl 6():s71-7. PubMed ID: 25468925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics Data Analysis of Next-Generation Sequencing Data from Heterogeneous Tumor Samples.
    Landman SR; Hwang TH
    Methods Mol Biol; 2017; 1633():185-192. PubMed ID: 28735488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical next generation sequencing in cancer.
    Pfeifer JD
    Cancer Genet; 2013 Dec; 206(12):409-12. PubMed ID: 24345338
    [No Abstract]   [Full Text] [Related]  

  • 6. More Pitfalls Related to Next-generation Sequencing (NGS).
    Sorscher S
    Am J Clin Oncol; 2016 Aug; 39(4):424. PubMed ID: 27465427
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical applications of next-generation sequencing.
    Kubo M
    Clin Adv Hematol Oncol; 2012 Jul; 10(7):462-4. PubMed ID: 22895287
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications.
    Lo YM; Chiu RW
    J Pathol; 2011 Nov; 225(3):318-23. PubMed ID: 21984122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing of formalin-fixed, paraffin-embedded tumor biopsies: navigating the perils of old and new technology to advance cancer diagnosis.
    Latham GJ
    Expert Rev Mol Diagn; 2013 Nov; 13(8):769-72. PubMed ID: 24117229
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.
    Kuderer NM; Burton KA; Blau S; Rose AL; Parker S; Lyman GH; Blau CA
    JAMA Oncol; 2017 Jul; 3(7):996-998. PubMed ID: 27978570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implementation of next-generation sequencing.
    Press RD
    Clin Adv Hematol Oncol; 2014 Apr; 12(4):263-5. PubMed ID: 25003357
    [No Abstract]   [Full Text] [Related]  

  • 12. DNA hypomethylation in plasma as a cancer biomarker: when less is more?
    Henrique R; Jerónimo C
    Expert Rev Mol Diagn; 2014 May; 14(4):419-22. PubMed ID: 24689646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next generation sequencing and bioinformatic bottlenecks: the current state of metagenomic data analysis.
    Scholz MB; Lo CC; Chain PS
    Curr Opin Biotechnol; 2012 Feb; 23(1):9-15. PubMed ID: 22154470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fourth Generation of Next-Generation Sequencing Technologies: Promise and Consequences.
    Ke R; Mignardi M; Hauling T; Nilsson M
    Hum Mutat; 2016 Dec; 37(12):1363-1367. PubMed ID: 27406789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of amplicon-based next-generation sequencing in cancer.
    Chang F; Li MM
    Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeTiN: overcoming tumor-in-normal contamination.
    Taylor-Weiner A; Stewart C; Giordano T; Miller M; Rosenberg M; Macbeth A; Lennon N; Rheinbay E; Landau DA; Wu CJ; Getz G
    Nat Methods; 2018 Jul; 15(7):531-534. PubMed ID: 29941871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic technologies and the new era of genomic medicine.
    Ankala A; Hegde M
    J Mol Diagn; 2014 Jan; 16(1):7-10. PubMed ID: 24269227
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Applications of Next-Generation Sequencing in Cancer Diagnosis.
    Sabour L; Sabour M; Ghorbian S
    Pathol Oncol Res; 2017 Apr; 23(2):225-234. PubMed ID: 27722982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.